EPS for Medidata Solutions, Inc. (MDSO) Expected At $0.22

June 17, 2018 - By Louis Casey

Medidata Solutions, Inc. (NASDAQ:MDSO) LogoInvestors sentiment decreased to 0.95 in 2018 Q1. Its down 0.76, from 1.71 in 2017Q4. It fall, as 36 investors sold Medidata Solutions, Inc. shares while 74 reduced holdings. 28 funds opened positions while 76 raised stakes. 62.26 million shares or 1.96% more from 61.06 million shares in 2017Q4 were reported.
New York-based Eulav Asset Mgmt has invested 0.53% in Medidata Solutions, Inc. (NASDAQ:MDSO). California Public Employees Retirement reported 102,913 shares. Employees Retirement Sys Of Ohio holds 0.04% or 119,827 shares in its portfolio. Moreover, Liberty Mutual Gru Asset Management Incorporated has 0.02% invested in Medidata Solutions, Inc. (NASDAQ:MDSO). Wells Fargo & Mn holds 0% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 187,325 shares. 79,779 were accumulated by Parametric Assocs Limited Liability Company. Cornerstone Advisors holds 15 shares. Secor Capital Advsr Lp reported 94,651 shares. The Ohio-based Carnegie Capital Asset Mgmt Limited Liability Company has invested 0.06% in Medidata Solutions, Inc. (NASDAQ:MDSO). Old Mutual Global Investors (Uk) Ltd invested in 0.01% or 15,651 shares. Arizona State Retirement reported 0.03% in Medidata Solutions, Inc. (NASDAQ:MDSO). Conestoga Capital Advsr Limited Liability owns 1.7% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 707,677 shares. Canada Pension Plan Invest Board holds 1.08M shares or 0.11% of its portfolio. Fmr Ltd Liability Corporation has invested 0.01% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Fund Mgmt invested in 153,897 shares or 0.06% of the stock.

Since December 19, 2017, it had 0 buys, and 11 insider sales for $5.97 million activity. The insider Otner Michael I. sold $728,170. $1.88 million worth of Medidata Solutions, Inc. (NASDAQ:MDSO) shares were sold by de Vries Glen Michael. TAYLOR ROBERT also sold $285,681 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) on Monday, June 4. Sherif Tarek sold $1.89 million worth of stock or 26,836 shares.

Analysts expect Medidata Solutions, Inc. (NASDAQ:MDSO) to report $0.22 EPS on July, 17.They anticipate $0.04 EPS change or 22.22 % from last quarter’s $0.18 EPS. MDSO’s profit would be $13.02 million giving it 93.33 P/E if the $0.22 EPS is correct. After having $0.24 EPS previously, Medidata Solutions, Inc.’s analysts see -8.33 % EPS growth. The stock increased 1.40% or $1.13 during the last trading session, reaching $82.13. About 551,531 shares traded. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 4.39% since June 17, 2017 and is uptrending. It has underperformed by 8.18% the S&P500.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Among 10 analysts covering Medidata Solutions (NASDAQ:MDSO), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Medidata Solutions had 14 analyst reports since January 3, 2018 according to SRatingsIntel. KeyBanc Capital Markets maintained the stock with “Buy” rating in Wednesday, January 3 report. RBC Capital Markets maintained the stock with “Hold” rating in Thursday, February 8 report. Deutsche Bank maintained it with “Buy” rating and $8500 target in Thursday, May 31 report. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, June 12 report. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, May 23. Morgan Stanley maintained the shares of MDSO in report on Friday, February 9 with “Overweight” rating. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Buy” rating by Needham on Friday, April 20. Piper Jaffray maintained it with “Buy” rating and $83.0 target in Thursday, February 8 report. Dougherty maintained Medidata Solutions, Inc. (NASDAQ:MDSO) on Thursday, May 10 with “Buy” rating. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) has “Buy” rating given on Wednesday, June 13 by Deutsche Bank.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide. The company has market cap of $4.86 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. It has a 110.99 P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

More important recent Medidata Solutions, Inc. (NASDAQ:MDSO) news were published by: Seekingalpha.com which released: “Medidata Solutions acquires SHYFT Analytics for $195M in cash” on June 12, 2018, also Seekingalpha.com published article titled: “Premarket analyst action – healthcare”, Streetinsider.com published: “Medidata Solutions (MDSO) PT Raised to $85 at Deutsche Bank” on May 31, 2018. More interesting news about Medidata Solutions, Inc. (NASDAQ:MDSO) was released by: Benzinga.com and their article: “Benzinga’s Top Upgrades, Downgrades For June 15, 2018” with publication date: June 15, 2018.

Medidata Solutions, Inc. (NASDAQ:MDSO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: